Revelation Biosciences (REVB)
(Delayed Data from NSDQ)
$1.95 USD
+0.11 (5.69%)
Updated May 15, 2024 04:00 PM ET
After-Market: $1.99 +0.04 (2.05%) 7:16 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -5.17 |
EPS Last Quarter | -2.46 |
Last EPS Surprise | 54.36% |
ABR | 1.00 |
Earnings ESP
|
74.08% |
---|---|
Current Year | -20.59 |
Next Year | -18.99 |
EPS (TTM) | -30.61 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -5.17 | -5.22 | -20.59 | -18.99 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -5.18 | -5.21 | -20.32 | -18.88 |
High Estimate | -1.34 | -1.44 | -5.44 | -3.47 |
Low Estimate | -9.00 | -9.00 | -35.73 | -34.50 |
Year ago EPS | -7.51 | -12.31 | -36.96 | -20.59 |
Year over Year Growth Est. | 31.16% | 57.60% | 44.29% | 7.77% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 1 | 1 | 1 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -5.17 | -5.22 | -20.59 | -18.99 |
7 Days Ago | -5.18 | -5.21 | -20.32 | -18.88 |
30 Days Ago | -5.18 | -5.21 | -20.32 | -18.88 |
60 Days Ago | -4.81 | -6.75 | -20.77 | -21.32 |
90 Days Ago | -10.51 | -13.21 | -46.25 | -57.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.34 | -1.44 | -5.44 | -3.47 |
Zacks Consensus Estimate | -5.17 | -5.22 | -20.59 | -18.99 |
Earnings ESP | 74.08% | 72.41% | 73.57% | 81.72% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.46 | -8.33 | -12.31 | -7.51 | NA |
Estimate | -5.39 | -10.94 | -9.01 | -9.91 | NA |
Difference | 2.93 | 2.61 | -3.30 | 2.40 | 1.16 |
Surprise | 54.36% | 23.86% | -36.67% | 24.24% | 16.45% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more